Header Logo

Laurel Habel

Concepts (560)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
85
2024
957
10.990
Why?
Mammography
26
2024
169
4.500
Why?
Neoplasm Recurrence, Local
24
2023
247
3.610
Why?
Carcinoma, Intraductal, Noninfiltrating
12
2020
40
3.400
Why?
Neoplasms
17
2023
445
2.900
Why?
Middle Aged
126
2025
8020
2.820
Why?
Humans
178
2025
17822
2.810
Why?
Breast
16
2023
85
2.800
Why?
Prostatic Neoplasms
15
2020
262
2.690
Why?
Female
142
2025
12780
2.680
Why?
Breast Density
8
2024
31
2.660
Why?
Aged
92
2024
6173
2.160
Why?
Adult
92
2024
7708
2.100
Why?
Hypoglycemic Agents
10
2015
272
1.950
Why?
Risk Factors
64
2024
3362
1.920
Why?
Carcinoma, Ductal, Breast
10
2020
53
1.880
Why?
Biomarkers, Tumor
11
2021
144
1.870
Why?
Case-Control Studies
42
2023
1120
1.770
Why?
Cohort Studies
50
2023
2590
1.760
Why?
California
44
2020
2328
1.610
Why?
Receptor, ErbB-2
8
2023
46
1.520
Why?
Thiazolidinediones
7
2015
52
1.480
Why?
Diabetes Mellitus, Type 2
9
2015
755
1.450
Why?
Aged, 80 and over
35
2024
1931
1.380
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8
2017
172
1.350
Why?
Pancreatic Neoplasms
3
2023
67
1.330
Why?
Genetic Predisposition to Disease
13
2025
376
1.310
Why?
Male
68
2025
10145
1.280
Why?
Adenocarcinoma
9
2023
173
1.270
Why?
Lung Neoplasms
6
2021
260
1.230
Why?
Colorectal Neoplasms
6
2017
615
1.210
Why?
Antineoplastic Agents, Hormonal
7
2020
64
1.210
Why?
Antihypertensive Agents
5
2020
161
1.190
Why?
Women's Health
12
2022
202
1.180
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2016
47
1.140
Why?
Registries
19
2020
472
1.100
Why?
Attention Deficit Disorder with Hyperactivity
5
2011
64
1.060
Why?
Risk
19
2020
518
1.060
Why?
Risk Assessment
19
2020
1103
1.020
Why?
Mastectomy, Segmental
6
2020
20
1.020
Why?
Proportional Hazards Models
22
2022
711
1.020
Why?
Liver Neoplasms
2
2016
40
0.980
Why?
Follow-Up Studies
27
2017
1219
0.930
Why?
Carcinoma
2
2015
22
0.920
Why?
Retrospective Studies
21
2023
2467
0.920
Why?
Drug-Related Side Effects and Adverse Reactions
3
2009
107
0.910
Why?
Incidence
23
2016
1269
0.890
Why?
Urinary Bladder Neoplasms
4
2015
56
0.850
Why?
Smoking
10
2015
484
0.850
Why?
European Continental Ancestry Group
11
2020
529
0.840
Why?
Prognosis
19
2023
609
0.840
Why?
Neoplasm Staging
17
2020
330
0.830
Why?
Menarche
3
2024
28
0.810
Why?
Drug Prescriptions
4
2016
151
0.790
Why?
Central Nervous System Stimulants
4
2011
27
0.790
Why?
Herpes Zoster
2
2014
82
0.780
Why?
Adiposity
2
2024
66
0.760
Why?
Carcinoma in Situ
5
2009
17
0.760
Why?
Continental Population Groups
9
2017
302
0.720
Why?
Neoplasms, Second Primary
4
2022
29
0.720
Why?
Polymorphism, Single Nucleotide
11
2025
379
0.680
Why?
Diabetes Mellitus, Type 1
2
2013
121
0.670
Why?
Odds Ratio
15
2017
673
0.670
Why?
Gene Expression Regulation, Neoplastic
6
2015
51
0.650
Why?
Menopause
6
2011
69
0.650
Why?
Neoplasm Invasiveness
8
2017
78
0.640
Why?
Body Mass Index
14
2015
967
0.610
Why?
Fractures, Bone
1
2019
95
0.610
Why?
Genome-Wide Association Study
10
2025
249
0.600
Why?
Mammary Glands, Human
3
2015
8
0.590
Why?
Alaska Natives
1
2017
5
0.590
Why?
Antidepressive Agents
1
2019
156
0.590
Why?
Reverse Transcriptase Polymerase Chain Reaction
5
2014
27
0.580
Why?
Adolescent
22
2024
3690
0.580
Why?
Neoplasms, Multiple Primary
3
2025
18
0.580
Why?
Indians, North American
1
2017
49
0.580
Why?
Managed Care Programs
2
2010
325
0.570
Why?
Paroxetine
2
2015
23
0.570
Why?
Antidepressive Agents, Second-Generation
2
2015
28
0.560
Why?
Young Adult
16
2024
2464
0.560
Why?
Cost of Illness
2
2009
93
0.560
Why?
Gallbladder
1
2017
1
0.550
Why?
Metformin
3
2015
58
0.550
Why?
Lip Neoplasms
2
2017
2
0.550
Why?
Drug Utilization Review
2
2007
25
0.550
Why?
Hydrochlorothiazide
2
2017
5
0.550
Why?
Cholinergic Antagonists
1
2017
6
0.550
Why?
Legislation, Medical
1
2016
5
0.550
Why?
Homeodomain Proteins
2
2015
16
0.540
Why?
Logistic Models
15
2021
928
0.540
Why?
Phosphodiesterase 5 Inhibitors
1
2016
4
0.540
Why?
Sildenafil Citrate
1
2016
4
0.540
Why?
Disclosure
1
2016
19
0.540
Why?
Child Health Services
2
2009
113
0.540
Why?
Hypercholesterolemia
1
2016
32
0.530
Why?
Immunocompromised Host
2
2014
18
0.530
Why?
Pharmacoepidemiology
3
2023
18
0.520
Why?
Melanoma
1
2016
35
0.520
Why?
Practice Patterns, Physicians'
3
2017
332
0.520
Why?
Magnetic Resonance Imaging
1
2016
107
0.510
Why?
Time Factors
13
2023
1097
0.510
Why?
Receptors, Estrogen
6
2016
51
0.510
Why?
Benzodiazepines
2
2015
29
0.500
Why?
United States
17
2019
4007
0.490
Why?
Anti-Bacterial Agents
2
2007
142
0.490
Why?
Body Constitution
3
2007
41
0.490
Why?
Gene Expression Profiling
5
2023
34
0.480
Why?
C-Reactive Protein
1
2015
59
0.470
Why?
Receptors, Progesterone
7
2023
50
0.470
Why?
Confounding Factors (Epidemiology)
6
2016
86
0.460
Why?
Neuralgia
1
2014
3
0.460
Why?
Exercise
4
2016
495
0.460
Why?
Antineoplastic Agents
5
2023
59
0.460
Why?
Peritoneal Neoplasms
1
2014
2
0.450
Why?
Ovariectomy
1
2014
9
0.450
Why?
Ethnic Groups
8
2017
485
0.450
Why?
Testicular Neoplasms
1
2013
11
0.450
Why?
Fluoxetine
1
2013
26
0.450
Why?
Hysterectomy
1
2014
29
0.440
Why?
Carcinoma, Ductal
2
2011
4
0.440
Why?
Barrett Esophagus
7
2008
114
0.440
Why?
Insulin, Long-Acting
1
2013
11
0.440
Why?
Gonadal Steroid Hormones
4
2017
27
0.430
Why?
Serotonin Uptake Inhibitors
1
2013
71
0.430
Why?
Ovarian Neoplasms
1
2014
50
0.430
Why?
Receptors, Interleukin
1
2013
4
0.430
Why?
Mass Screening
3
2016
678
0.420
Why?
Lymph Nodes
1
2013
17
0.420
Why?
Cardiovascular Diseases
3
2016
599
0.410
Why?
Nifedipine
1
2012
7
0.410
Why?
Tumor Suppressor Protein p53
2
2023
20
0.410
Why?
Stomach Neoplasms
3
2002
41
0.410
Why?
Mendelian Randomization Analysis
2
2024
25
0.410
Why?
Herpesvirus 3, Human
1
2012
44
0.400
Why?
Chemotherapy, Adjuvant
8
2020
74
0.400
Why?
Tamoxifen
4
2016
56
0.390
Why?
Reproductive History
2
2011
17
0.390
Why?
Thyroxine
1
2011
6
0.390
Why?
Data Interpretation, Statistical
2
2011
77
0.390
Why?
In Situ Hybridization, Fluorescence
2
2012
14
0.380
Why?
Breast Neoplasms, Male
3
2015
10
0.370
Why?
Norepinephrine
1
2011
2
0.370
Why?
Alcoholism
1
2015
348
0.370
Why?
Colonic Neoplasms
2
2011
158
0.370
Why?
Breast Diseases
2
2008
18
0.360
Why?
Metabolic Syndrome
1
2011
81
0.350
Why?
Carcinoma, Lobular
3
2012
10
0.350
Why?
Helicobacter Infections
3
2008
22
0.350
Why?
Helicobacter pylori
3
2008
24
0.350
Why?
Longitudinal Studies
6
2015
720
0.340
Why?
Drug Evaluation, Preclinical
1
2009
4
0.340
Why?
Physical Fitness
1
2010
73
0.340
Why?
Pharmaceutical Preparations
1
2009
11
0.340
Why?
Tobacco Smoke Pollution
1
2010
34
0.340
Why?
Combined Modality Therapy
3
2020
147
0.330
Why?
SEER Program
5
2016
91
0.330
Why?
Mutation
3
2023
131
0.320
Why?
Age Distribution
6
2012
246
0.320
Why?
Antibodies, Monoclonal, Humanized
3
2014
24
0.320
Why?
Transcriptome
3
2025
25
0.320
Why?
Maternal Welfare
1
2009
14
0.320
Why?
Precancerous Conditions
3
2008
47
0.320
Why?
Colonoscopy
2
2008
253
0.310
Why?
Asian Continental Ancestry Group
5
2017
90
0.310
Why?
Early Detection of Cancer
5
2023
513
0.310
Why?
Disabled Children
1
2009
28
0.300
Why?
Methylphenidate
1
2007
4
0.300
Why?
Hypertension
3
2020
505
0.300
Why?
Sentinel Surveillance
1
2007
12
0.290
Why?
Treatment Outcome
7
2020
1265
0.290
Why?
Mothers
1
2009
106
0.290
Why?
Colonic Polyps
1
2007
35
0.290
Why?
Dairy Products
1
2007
22
0.280
Why?
Child
8
2024
2497
0.280
Why?
Anti-Inflammatory Agents, Non-Steroidal
3
2007
65
0.280
Why?
Cholesterol
2
2017
106
0.270
Why?
Mental Health Services
1
2009
159
0.270
Why?
Pathology, Clinical
2
2010
14
0.270
Why?
Health Care Costs
1
2009
229
0.270
Why?
Aspirin
2
2007
63
0.260
Why?
Selective Estrogen Receptor Modulators
1
2006
11
0.260
Why?
Raloxifene Hydrochloride
1
2006
12
0.260
Why?
Estrogen Replacement Therapy
5
2008
99
0.260
Why?
Antibodies, Viral
3
2024
65
0.260
Why?
Blood Glucose
1
2008
349
0.250
Why?
Electronic Health Records
5
2015
698
0.250
Why?
Asthma
1
2009
387
0.250
Why?
Condylomata Acuminata
4
1998
23
0.250
Why?
Denmark
4
2020
18
0.250
Why?
Alcohol Drinking
4
2020
373
0.250
Why?
Age Factors
11
2016
923
0.250
Why?
State Health Plans
1
2005
35
0.240
Why?
Recurrence
6
2023
189
0.240
Why?
Spike Glycoprotein, Coronavirus
1
2024
4
0.230
Why?
Radiotherapy, Adjuvant
2
2017
18
0.230
Why?
Life Style
5
2016
334
0.230
Why?
Confidence Intervals
6
2016
237
0.230
Why?
Algorithms
5
2023
239
0.230
Why?
Dose-Response Relationship, Drug
4
2017
129
0.220
Why?
Diuretics
2
2017
17
0.220
Why?
Postmenopause
5
2011
243
0.220
Why?
Antigens, Bacterial
2
2007
8
0.220
Why?
Bacterial Proteins
2
2007
13
0.220
Why?
Proto-Oncogene Proteins p21(ras)
1
2023
21
0.210
Why?
Socioeconomic Factors
4
2020
630
0.210
Why?
Anti-Mullerian Hormone
1
2022
2
0.200
Why?
Prospective Studies
10
2020
1286
0.200
Why?
Surveys and Questionnaires
7
2016
1323
0.200
Why?
Estrogen Receptor alpha
4
2015
25
0.200
Why?
Prevalence
5
2017
888
0.200
Why?
Calcium Channel Blockers
2
2020
14
0.190
Why?
Genetic Testing
3
2017
72
0.190
Why?
Survival Rate
3
2017
260
0.190
Why?
Comorbidity
2
2017
597
0.180
Why?
Carcinoma, Squamous Cell
2
2017
55
0.180
Why?
Sensitivity and Specificity
3
2015
305
0.180
Why?
Sexual Behavior
3
1998
124
0.180
Why?
African Americans
4
2015
472
0.180
Why?
Molecular Epidemiology
1
2021
44
0.180
Why?
Sleep Wake Disorders
1
2021
37
0.180
Why?
Multifactorial Inheritance
1
2020
20
0.180
Why?
Carcinoma, Renal Cell
1
2020
10
0.180
Why?
Kidney Neoplasms
1
2020
16
0.180
Why?
Carcinogenesis
1
2020
9
0.180
Why?
Cross-Sectional Studies
4
2024
1335
0.180
Why?
Data Collection
2
2012
257
0.180
Why?
Premenopause
4
2022
25
0.180
Why?
Linear Models
3
2011
232
0.180
Why?
Hair
1
2000
7
0.170
Why?
Face
1
2000
5
0.170
Why?
Gastroesophageal Reflux
4
2008
79
0.170
Why?
Regional Medical Programs
1
2020
2
0.170
Why?
Depression
2
2015
506
0.170
Why?
Health Maintenance Organizations
6
2009
417
0.170
Why?
Prostate-Specific Antigen
3
2017
75
0.170
Why?
Heart Failure
3
2016
396
0.170
Why?
Child, Preschool
4
2011
1424
0.170
Why?
Multivariate Analysis
5
2015
569
0.170
Why?
Tobacco Smoking
1
2020
20
0.170
Why?
Trastuzumab
3
2014
14
0.170
Why?
Health Plan Implementation
1
2020
36
0.170
Why?
Anthropometry
2
2017
66
0.170
Why?
Protective Factors
2
2016
32
0.170
Why?
Delivery of Health Care, Integrated
4
2017
537
0.170
Why?
Reproducibility of Results
4
2015
381
0.160
Why?
Barbiturates
1
1999
1
0.160
Why?
Abdominal Fat
2
2011
14
0.160
Why?
Immunoenzyme Techniques
3
2014
20
0.160
Why?
Behavior
2
2017
18
0.160
Why?
Accidental Falls
1
2019
42
0.160
Why?
RNA, Messenger
3
2014
72
0.160
Why?
Neoplasm Grading
3
2014
49
0.160
Why?
Phenobarbital
1
1998
2
0.160
Why?
Esophageal Neoplasms
5
2008
115
0.160
Why?
Drug Utilization
2
2017
128
0.160
Why?
Propensity Score
1
2019
85
0.160
Why?
Aging
1
2000
163
0.160
Why?
Telemedicine
1
2022
187
0.160
Why?
Hypnotics and Sedatives
1
1998
18
0.160
Why?
Parity
2
2010
74
0.160
Why?
Kaplan-Meier Estimate
3
2014
129
0.150
Why?
Genital Diseases, Female
1
1998
9
0.150
Why?
Osteoporosis
1
2019
78
0.150
Why?
Biomarkers
3
2015
310
0.150
Why?
Organizations, Nonprofit
2
2009
11
0.150
Why?
Lymphoma
1
2017
6
0.150
Why?
Quality Improvement
1
2020
194
0.150
Why?
Bone Density
3
2007
97
0.150
Why?
Datasets as Topic
1
2017
20
0.150
Why?
Biopsy
3
2009
75
0.150
Why?
Disease-Free Survival
2
2015
58
0.150
Why?
Blood Pressure
1
2019
303
0.140
Why?
Bias
3
2023
103
0.140
Why?
Sigmoidoscopy
2
2007
65
0.140
Why?
Multiple Myeloma
1
2017
9
0.140
Why?
African Continental Ancestry Group
3
2017
162
0.140
Why?
Databases, Factual
4
2017
315
0.140
Why?
Rosacea
2
2007
3
0.140
Why?
Immunohistochemistry
2
2014
44
0.140
Why?
Acne Vulgaris
2
2007
8
0.140
Why?
Social Class
1
2017
121
0.140
Why?
Specimen Handling
1
2017
20
0.140
Why?
Adrenergic beta-Antagonists
2
2022
43
0.140
Why?
Medication Adherence
1
2020
246
0.140
Why?
Washington
5
1998
383
0.140
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2016
2
0.140
Why?
Child Health
1
2017
35
0.140
Why?
Proto-Oncogene Proteins B-raf
1
2016
15
0.130
Why?
Neoplasm Proteins
1
2016
9
0.130
Why?
Genetic Loci
1
2017
55
0.130
Why?
Aspartate Aminotransferases
1
2016
13
0.130
Why?
Causality
1
2016
40
0.130
Why?
Predictive Value of Tests
3
2015
354
0.130
Why?
Research
1
2017
65
0.130
Why?
Tumor Burden
2
2013
19
0.130
Why?
Research Design
3
2015
376
0.130
Why?
Alanine Transaminase
1
2016
22
0.130
Why?
Child Development
1
2017
54
0.130
Why?
Contraceptives, Oral
1
1996
26
0.130
Why?
Metabolic Equivalent
1
2016
8
0.130
Why?
Diabetes Mellitus
3
2010
487
0.130
Why?
Outcome Assessment (Health Care)
1
2017
228
0.130
Why?
Pregnancy
5
2010
1529
0.130
Why?
Insulin-Like Growth Factor I
1
2016
14
0.130
Why?
Motor Activity
2
2015
212
0.130
Why?
Polymerase Chain Reaction
2
2012
49
0.130
Why?
Anthracyclines
2
2012
14
0.130
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
86
0.130
Why?
Breast Feeding
2
2015
137
0.130
Why?
Nomograms
1
2015
11
0.120
Why?
Pathology Department, Hospital
1
2015
3
0.120
Why?
Women, Working
1
1995
6
0.120
Why?
Obesity
2
2015
842
0.120
Why?
Diphosphonates
1
2016
65
0.120
Why?
Estrogens
3
2010
61
0.120
Why?
Occupational Diseases
1
1995
41
0.120
Why?
Inflammation
1
2015
64
0.120
Why?
Molecular Targeted Therapy
1
2014
6
0.120
Why?
Cardiomyopathies
1
2014
10
0.110
Why?
Proteinuria
1
2014
26
0.110
Why?
Insurance Claim Review
1
2014
61
0.110
Why?
Insulin Glargine
1
2013
9
0.110
Why?
Carcinoma, Basal Cell
1
2014
24
0.110
Why?
Reference Values
2
2012
93
0.110
Why?
Real-Time Polymerase Chain Reaction
1
2013
12
0.110
Why?
Stroke
2
2016
315
0.100
Why?
Hematologic Neoplasms
1
2012
7
0.100
Why?
Residence Characteristics
1
2015
251
0.100
Why?
Hormones
2
2015
14
0.100
Why?
Patient Acceptance of Health Care
1
2016
391
0.100
Why?
Estradiol
2
2015
24
0.100
Why?
Sex Distribution
1
2012
190
0.100
Why?
Cyclohexanecarboxylic Acids
1
2011
4
0.100
Why?
Amines
1
2011
5
0.100
Why?
gamma-Aminobutyric Acid
1
2011
5
0.100
Why?
Anticonvulsants
1
2011
9
0.100
Why?
Phenotype
2
2022
151
0.100
Why?
Iron
2
2008
16
0.100
Why?
Death, Sudden, Cardiac
1
2011
35
0.100
Why?
Menstruation
1
2011
7
0.090
Why?
Sulfonylurea Compounds
2
2010
25
0.090
Why?
Densitometry
1
2011
1
0.090
Why?
Carcinoma, Non-Small-Cell Lung
1
2012
50
0.090
Why?
Prazosin
1
2011
1
0.090
Why?
Clonidine
1
2011
3
0.090
Why?
Propranolol
1
2011
4
0.090
Why?
Metoprolol
1
2011
6
0.090
Why?
Atenolol
1
2011
8
0.090
Why?
Perimenopause
2
2009
11
0.090
Why?
Adipose Tissue
2
2009
64
0.090
Why?
Health Services Research
1
2012
232
0.090
Why?
Dietary Supplements
1
2011
87
0.090
Why?
Chromosomes, Human, Pair 17
1
2010
3
0.090
Why?
False Negative Reactions
1
2010
12
0.090
Why?
Vitamins
1
2011
64
0.090
Why?
False Positive Reactions
1
2010
26
0.090
Why?
Laboratories
1
2010
18
0.090
Why?
Insulin
2
2010
213
0.090
Why?
Age of Onset
2
2007
79
0.090
Why?
Medical Audit
1
2010
39
0.090
Why?
Estrogen Antagonists
1
2010
3
0.090
Why?
Fetus
1
1990
6
0.090
Why?
Massachusetts
1
2010
94
0.090
Why?
Narcotics
1
1990
7
0.090
Why?
Carcinogenicity Tests
1
2009
2
0.090
Why?
Carcinogens
1
2009
3
0.090
Why?
Maternal-Fetal Exchange
1
1990
13
0.080
Why?
Infant Mortality
1
1990
20
0.080
Why?
Myocardial Infarction
1
2011
238
0.080
Why?
Diabetes Complications
1
2010
114
0.080
Why?
Glycated Hemoglobin A
1
2010
216
0.080
Why?
Adenoma
1
2010
94
0.080
Why?
Substance-Related Disorders
2
1993
434
0.080
Why?
Ligands
1
2008
6
0.080
Why?
Ferritins
1
2008
9
0.080
Why?
Antiprotozoal Agents
1
2008
2
0.080
Why?
Furosemide
1
2008
2
0.080
Why?
Griseofulvin
1
2008
2
0.080
Why?
Metronidazole
1
2008
4
0.080
Why?
Antifungal Agents
1
2008
4
0.080
Why?
Hemochromatosis
1
2008
7
0.080
Why?
Histocompatibility Antigens Class I
1
2008
7
0.080
Why?
Neoplasms, Hormone-Dependent
1
2008
8
0.080
Why?
Pennsylvania
1
2008
25
0.070
Why?
Delivery of Health Care
1
2012
417
0.070
Why?
Glycemic Index
1
2008
20
0.070
Why?
Membrane Proteins
1
2008
39
0.070
Why?
Lovastatin
1
2008
7
0.070
Why?
Amphetamines
1
2007
2
0.070
Why?
Leukemia, Lymphoid
1
2007
2
0.070
Why?
Pemoline
1
2007
2
0.070
Why?
Genomics
2
2020
55
0.070
Why?
Clinical Pharmacy Information Systems
1
2007
10
0.070
Why?
Simvastatin
1
2008
11
0.070
Why?
Thyroid Neoplasms
1
2007
12
0.070
Why?
Randomized Controlled Trials as Topic
2
2011
329
0.070
Why?
Insurance Carriers
1
2007
6
0.070
Why?
Ibuprofen
1
2007
9
0.070
Why?
Patient Compliance
1
2009
301
0.070
Why?
Tetracyclines
1
2006
2
0.070
Why?
Macrolides
1
2006
7
0.070
Why?
Risk Adjustment
1
2006
24
0.070
Why?
Esophageal Sphincter, Lower
1
2006
3
0.070
Why?
Prepaid Health Plans
1
2006
20
0.070
Why?
Survivors
3
2015
150
0.070
Why?
Deductibles and Coinsurance
1
2006
30
0.070
Why?
Alleles
2
2017
85
0.060
Why?
Single-Blind Method
1
2004
45
0.060
Why?
Seroepidemiologic Studies
1
2024
18
0.060
Why?
Glioma
1
2004
5
0.060
Why?
Weight Gain
1
2006
173
0.060
Why?
Brain Neoplasms
1
2004
15
0.060
Why?
Body Size
1
2024
31
0.060
Why?
Health Status
1
2006
299
0.060
Why?
International Cooperation
2
2015
17
0.060
Why?
Health Behavior
1
2006
360
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2006
382
0.050
Why?
Mastectomy
1
2023
36
0.050
Why?
HIV Infections
1
2009
707
0.050
Why?
Artificial Intelligence
1
2023
21
0.050
Why?
Whole Exome Sequencing
1
2022
8
0.050
Why?
Exome
1
2022
21
0.050
Why?
Vaccination
2
2024
655
0.050
Why?
Multicenter Studies as Topic
2
2012
86
0.050
Why?
Sudden Infant Death
2
1993
10
0.050
Why?
Mental Disorders
1
2005
280
0.050
Why?
Skin Neoplasms
1
2002
57
0.050
Why?
Hispanic Americans
2
2015
404
0.050
Why?
Survival Analysis
2
2012
216
0.050
Why?
Prescriptions
1
2021
27
0.050
Why?
Observer Variation
1
2001
37
0.050
Why?
Epidemiologic Studies
1
2001
29
0.050
Why?
Sleep
1
2021
58
0.040
Why?
Genetic Pleiotropy
1
2020
9
0.040
Why?
Genotype
1
2021
227
0.040
Why?
Body Height
1
2000
62
0.040
Why?
Diet
2
2010
366
0.040
Why?
Pandemics
1
2022
287
0.040
Why?
Sex Factors
3
2010
644
0.040
Why?
Angiotensin Receptor Antagonists
1
2020
53
0.040
Why?
San Francisco
1
1999
64
0.040
Why?
Acquired Immunodeficiency Syndrome
2
1990
63
0.040
Why?
Epidemiologic Methods
1
1999
81
0.040
Why?
Genital Diseases, Male
1
1998
2
0.040
Why?
Double-Blind Method
2
2008
160
0.040
Why?
Oncologists
1
2017
7
0.030
Why?
Gene Frequency
1
2017
43
0.030
Why?
Gene Expression
1
2017
23
0.030
Why?
Prostate
1
2017
28
0.030
Why?
Morbidity
1
2017
59
0.030
Why?
Feasibility Studies
1
2017
114
0.030
Why?
Multigene Family
1
2016
7
0.030
Why?
Body Weight
2
2009
224
0.030
Why?
Drug Carriers
1
2016
1
0.030
Why?
Pathology, Molecular
1
2016
1
0.030
Why?
Heart Valve Diseases
1
2016
20
0.030
Why?
Drug Approval
1
2016
12
0.030
Why?
Pilot Projects
1
2017
219
0.030
Why?
Arrhythmias, Cardiac
1
2016
32
0.030
Why?
Administration, Oral
1
2016
85
0.030
Why?
Health Resources
1
2015
38
0.030
Why?
Capsid
1
1995
1
0.030
Why?
INDEL Mutation
1
2015
7
0.030
Why?
Progestins
1
1995
25
0.030
Why?
Androgens
1
2015
13
0.030
Why?
Cell Proliferation
1
2015
19
0.030
Why?
Quantitative Trait Loci
1
2015
38
0.030
Why?
Phylogeny
1
2015
14
0.030
Why?
Germ-Line Mutation
1
2015
18
0.030
Why?
Papillomaviridae
1
1995
58
0.030
Why?
Haplotypes
1
2015
34
0.030
Why?
Coronary Artery Disease
1
2016
134
0.030
Why?
Tobacco
1
2014
14
0.030
Why?
Guideline Adherence
1
2016
158
0.030
Why?
Chi-Square Distribution
2
2011
154
0.030
Why?
Radiotherapy Dosage
1
2014
3
0.030
Why?
Clinical Coding
1
2014
11
0.030
Why?
Utah
1
2014
33
0.030
Why?
New York City
2
1993
21
0.030
Why?
Heroin
1
1993
5
0.030
Why?
Cocaine
1
1993
6
0.030
Why?
Methadone
1
1993
10
0.030
Why?
Stroke Volume
1
2014
100
0.030
Why?
Taxoids
1
2012
8
0.030
Why?
Lymphatic Metastasis
1
2012
30
0.030
Why?
Antibiotics, Antineoplastic
1
2012
7
0.030
Why?
ROC Curve
1
2012
77
0.020
Why?
United Kingdom
1
2011
30
0.020
Why?
Health Personnel
1
2012
126
0.020
Why?
Prenatal Exposure Delayed Effects
1
1993
167
0.020
Why?
Infant, Newborn
2
1993
858
0.020
Why?
Patient Selection
1
2012
190
0.020
Why?
Clinical Trials as Topic
1
2011
132
0.020
Why?
Health Status Disparities
1
2012
147
0.020
Why?
Incretins
1
2010
2
0.020
Why?
Receptor, Insulin
1
2010
6
0.020
Why?
Receptor, IGF Type 1
1
2010
5
0.020
Why?
Practice Guidelines as Topic
1
2012
321
0.020
Why?
Hyperinsulinism
1
2010
10
0.020
Why?
Self Report
1
2012
253
0.020
Why?
Testosterone
1
2010
23
0.020
Why?
Cytokines
1
2010
30
0.020
Why?
Factor VIII
1
1990
2
0.020
Why?
Transfusion Reaction
1
1990
2
0.020
Why?
Factor IX
1
1990
3
0.020
Why?
Healthcare Disparities
1
2012
204
0.020
Why?
Cytochrome P-450 CYP1B1
1
2009
2
0.020
Why?
17-Hydroxysteroid Dehydrogenases
1
2009
3
0.020
Why?
Cytochrome P-450 CYP1A1
1
2009
6
0.020
Why?
Aromatase
1
2009
8
0.020
Why?
HIV-1
1
1990
73
0.020
Why?
Aryl Hydrocarbon Hydroxylases
1
2009
6
0.020
Why?
Estrogen Receptor beta
1
2009
10
0.020
Why?
Cytochrome P-450 Enzyme System
1
2009
8
0.020
Why?
Cause of Death
1
1990
181
0.020
Why?
Iron, Dietary
1
2008
7
0.020
Why?
Esophagoscopy
1
2008
19
0.020
Why?
Hemochromatosis Protein
1
2008
7
0.020
Why?
Homozygote
1
2008
13
0.020
Why?
Heterozygote
1
2008
26
0.020
Why?
Hyperplasia
1
2008
6
0.020
Why?
Overweight
1
2010
270
0.020
Why?
Men's Health
1
2007
20
0.020
Why?
Antibodies, Bacterial
1
2007
33
0.020
Why?
Drug Administration Schedule
1
2007
100
0.020
Why?
Fertility Agents, Female
1
2007
2
0.020
Why?
Hip
1
2007
9
0.020
Why?
Contraceptives, Oral, Hormonal
1
2007
12
0.020
Why?
Lumbar Vertebrae
1
2007
19
0.020
Why?
Thigh
1
2007
11
0.020
Why?
Waist-Hip Ratio
1
2007
23
0.020
Why?
Chemoprevention
1
2007
12
0.020
Why?
Education, Medical, Continuing
1
2007
30
0.020
Why?
Osteoporosis, Postmenopausal
1
2007
43
0.020
Why?
Secondary Prevention
1
2007
48
0.020
Why?
Muscle Relaxation
1
2006
3
0.020
Why?
Xanthines
1
2006
6
0.020
Why?
Nitrates
1
2006
8
0.020
Why?
Adrenergic beta-Agonists
1
2006
33
0.020
Why?
Anti-Asthmatic Agents
1
2006
85
0.020
Why?
Risk-Taking
1
2006
109
0.020
Why?
Rubella Vaccine
1
1985
8
0.020
Why?
Health Surveys
1
2006
261
0.020
Why?
Endoscopy, Digestive System
1
2002
10
0.010
Why?
Vaccinia virus
1
1995
1
0.010
Why?
Genetic Vectors
1
1995
2
0.010
Why?
DNA Primers
1
1995
7
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
1995
17
0.010
Why?
Base Sequence
1
1995
19
0.010
Why?
Molecular Sequence Data
1
1995
18
0.010
Why?
Drug Therapy, Combination
1
1995
115
0.010
Why?
Vitamin A
1
1994
14
0.010
Why?
Ascorbic Acid
1
1994
19
0.010
Why?
Urban Population
1
1993
116
0.010
Why?
Hot Temperature
1
1990
8
0.010
Why?
HIV Seropositivity
1
1990
31
0.010
Why?
Infant
1
1993
1198
0.010
Why?
Rubella
1
1985
6
0.000
Why?
Disease Outbreaks
1
1985
36
0.000
Why?
Immunization
1
1985
70
0.000
Why?
Concepts (560)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente